RESEARCH-USE BIOSIMILAR ANTIBODY

Camidanlumab

Antibody-drug conjugate · IgG1

CD25IgG1RUO

Camidanlumab (HuMax-TAC) is a humanized IgG1 monoclonal antibody against CD25. Camidanlumab can be used to synthesize the ADC molecule Camidanlumab tesirine (HY-141599). Camidanlumab can be used in the research of tumors such as lymphoma and leukemia. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

TARGETCD25
YAntibody-drug conjugate
CATALOGSC-BS-691
CATALOG NUMBERSC-BS-691
MOLECULAR WEIGHTApprox. 143.98 kDa
PRODUCT FORMATAntibody-drug conjugate

A research-use configuration for comparative antibody studies

Camidanlumab (HuMax-TAC) is a humanized IgG1 monoclonal antibody against CD25. Camidanlumab can be used to synthesize the ADC molecule Camidanlumab tesirine (HY-141599). Camidanlumab can be used in the research of tumors such as lymphoma and leukemia. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

Camidanlumab is a recombinant research-use antibody directed against CD25.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte